Author
Listed:
- Diletta Fontana
(University of Milano - Bicocca)
- Mario Mauri
(University of Milano - Bicocca)
- Rossella Renso
(University of Milano - Bicocca)
- Mattia Docci
(University of Milano - Bicocca)
- Ilaria Crespiatico
(University of Milano - Bicocca)
- Lisa M. Røst
(Norwegian University of Science and Technology)
- Mi Jang
(Norwegian University of Science and Technology)
- Antonio Niro
(University of Milano - Bicocca)
- Deborah D’Aliberti
(University of Milano - Bicocca)
- Luca Massimino
(University of Milano - Bicocca)
- Mayla Bertagna
(University of Milano - Bicocca)
- Giovanni Zambrotta
(University of Milano - Bicocca)
- Mario Bossi
(University of Milano - Bicocca)
- Stefania Citterio
(University of Milano - Bicocca)
- Barbara Crescenzi
(University of Perugia)
- Francesca Fanelli
(University of Modena and Reggio Emilia
University of Modena and Reggio Emilia)
- Valeria Cassina
(University of Milano - Bicocca)
- Roberta Corti
(University of Milano - Bicocca)
- Domenico Salerno
(University of Milano - Bicocca)
- Luca Nardo
(University of Milano - Bicocca)
- Clizia Chinello
(University of Milano - Bicocca)
- Francesco Mantegazza
(University of Milano - Bicocca)
- Cristina Mecucci
(University of Perugia)
- Fulvio Magni
(University of Milano - Bicocca)
- Guido Cavaletti
(University of Milano - Bicocca)
- Per Bruheim
(Norwegian University of Science and Technology)
- Delphine Rea
(Hôpital Saint-Louis)
- Steen Larsen
(University of Copenhagen
Medical University of Bialystok)
- Carlo Gambacorti-Passerini
(University of Milano - Bicocca
San Gerardo Hospital)
- Rocco Piazza
(University of Milano - Bicocca
San Gerardo Hospital
University of Milano - Bicocca)
Abstract
Recurrent somatic mutations in ETNK1 (Ethanolamine-Kinase-1) were identified in several myeloid malignancies and are responsible for a reduced enzymatic activity. Here, we demonstrate in primary leukemic cells and in cell lines that mutated ETNK1 causes a significant increase in mitochondrial activity, ROS production, and Histone H2AX phosphorylation, ultimately driving the increased accumulation of new mutations. We also show that phosphoethanolamine, the metabolic product of ETNK1, negatively controls mitochondrial activity through a direct competition with succinate at mitochondrial complex II. Hence, reduced intracellular phosphoethanolamine causes mitochondria hyperactivation, ROS production, and DNA damage. Treatment with phosphoethanolamine is able to counteract complex II hyperactivation and to restore a normal phenotype.
Suggested Citation
Diletta Fontana & Mario Mauri & Rossella Renso & Mattia Docci & Ilaria Crespiatico & Lisa M. Røst & Mi Jang & Antonio Niro & Deborah D’Aliberti & Luca Massimino & Mayla Bertagna & Giovanni Zambrotta &, 2020.
"ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine,"
Nature Communications, Nature, vol. 11(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19721-w
DOI: 10.1038/s41467-020-19721-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19721-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.